Genomic and phenotypic characterisation of invasive neonatal and colonising group B Streptococcus isolates from Slovenia, 2001–2018

Edmond KM(2012)Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis Lancet. 379 547-556

Kortsalioudaki C(2010)Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010 MMWR Recomm Rep 59 1-36

Scott S(2017)Invazivne okužbe novorojenčkov z bakterijo Streptococcus agalactiae v Sloveniji, 2003–2013 Zdrav Vestn 86 493-506

Schrag SJ(2005)Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens Clin Microbiol Rev 18 102-127

Zaidi AKM(2018)Perinatal Streptococcus agalactiae epidemiology and surveillance targets Clin Microbiol Rev 31 e00049-e00018

Cousens S(2018)Group B streptococcal colonization, molecular characteristics, and epidemiology Front Microbiol 9 437-1222

Verani JR(2008)Recent advances in understanding the molecular basis of group B Streptococcus virulence Expert Rev Mol Med 10 1209-2322

McGee L(2015)Srr2, a multifaceted adhesin expressed by ST-17 hypervirulent group B Streptococcus involved in binding to both fibrinogen and plasminogen Mol Microbiol 97 2313-3145

Schrag SJ(2010)The surface protein HvgA mediates group B Streptococcus hypervirulence and meningeal tropism in neonates J Exp Med 207 3140-354

Lasič M(1998)Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms Proc Natl Acad Sci U S A 95 350-1089

Edmond KM(2012)Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis Lancet. 379 547-556

Kortsalioudaki C(2010)Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010 MMWR Recomm Rep 59 1-36

Scott S(2017)Invazivne okužbe novorojenčkov z bakterijo Streptococcus agalactiae v Sloveniji, 2003–2013 Zdrav Vestn 86 493-506

Schrag SJ(2005)Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens Clin Microbiol Rev 18 102-127

Zaidi AKM(2018)Perinatal Streptococcus agalactiae epidemiology and surveillance targets Clin Microbiol Rev 31 e00049-e00018

Cousens S(2018)Group B streptococcal colonization, molecular characteristics, and epidemiology Front Microbiol 9 437-1222

Verani JR(2008)Recent advances in understanding the molecular basis of group B Streptococcus virulence Expert Rev Mol Med 10 1209-2322

McGee L(2015)Srr2, a multifaceted adhesin expressed by ST-17 hypervirulent group B Streptococcus involved in binding to both fibrinogen and plasminogen Mol Microbiol 97 2313-3145

Schrag SJ(2010)The surface protein HvgA mediates group B Streptococcus hypervirulence and meningeal tropism in neonates J Exp Med 207 3140-354

Lasič M(1998)Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms Proc Natl Acad Sci U S A 95 350-1089